一覧に戻るCompany

バイオスタートアップの米国市場挑戦 ― KICワシントンで出発

2022-02-16

KIC Washington D.C. Accelerator Collaborates with MassChallenge
Five companies to participate in Bio iCORE Program through 2023

https://www.hellodd.com/news/articleView.html?idxno=95343

The Bio iCORE program includes five companies selected as final global startup teams — NeuroEars, STEMDEN, RudaCure, and two others — and will run through March 2023.

MassChallenge prioritizes public benefit and the advancement of human welfare alongside profitability, and does not require equity or management rights from startups. This program is a collaboration between KIC DC and MassChallenge, providing promising Korean bio-tech companies with opportunities to meet global entrepreneurs, investors, and technology experts. It aims to support the successful global expansion of outstanding Korean bio startups through education, training, and mentoring.
一覧に戻る